Hienert G, Latal D, Rummelhardt S
Department of Urology, University of Vienna, Austria.
Semin Surg Oncol. 1988;4(2):137-8.
At the time of diagnosis one-third of patients with renal cell cancer are found to have metastatic spread. The patient's general condition and biological age as well as the resectability of the primary and/or secondary tumor decide whether surgery is indicated. Of our 44 patients, 12 underwent extirpation of metastases; 5-year survival was 47%. This is in agreement with published data. Patients with renal cell cancer and a solitary metastasis are, therefore, good candidates for surgery. In the presence of disseminated metastatic spread there is currently no place for tumor-reducing surgery because of the lack of effective adjuvant treatment modalities.
在诊断时，三分之一的肾细胞癌患者被发现已有转移扩散。患者的一般状况和生物学年龄以及原发和/或继发肿瘤的可切除性决定是否需要进行手术。在我们的44例患者中，12例接受了转移灶切除术；5年生存率为47%。这与已发表的数据一致。因此，患有肾细胞癌且有单个转移灶的患者是手术的良好候选者。由于缺乏有效的辅助治疗方式，对于存在广泛转移扩散的患者，目前不适合进行减瘤手术。
